Isao Tawara

15PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityHumoural immunology and immunochemistryCardiology (incl. cardiovascular diseases)Microfluidics and nanofluidics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 20, 2026
Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Early-Stage Breast Cancer with Preserved Baseline LVEF: Incidence of Cardiotoxicity and Feasibility of Simplified Cardiac Surveillance.

|Apr 01, 2026
New insights into JAK2 germline variant-driven stromal cell alterations and proinflammatory bone marrow niche remodeling in myeloproliferative neoplasms.

Komei Nishimura, Ryoichi Ono, Keiki Nagaharu

|Jan 10, 2026
Evaluation of Autoimmune FVIII Inhibitor Using Clot Waveform Analysis in Emicizumab-Treated Patients.

Shigehisa Tamaki, Hideo Wada, Naoki Shinke

|Nov 13, 2025
Diagnostic and Prognostic Evaluation of Disseminated Intravascular Coagulation Using the Disseminated Intravascular Coagulation Index.

Eri Nakano, Hideo Wada, Akitaka Yamamoto

|Jul 13, 2024
Evaluating Factor VIII Concentrates Using Clot Waveform Analysis.

Hideo Wada, Katsuya Shiraki, Takeshi Matsumoto

|Mar 07, 2024
Bahcc1 is critical for the aberrant epigenetic program in a mouse model of MLL-ENL-mediated leukemia.

Akihide Nakamura, Masahiro Masuya, Makoto Shinmei

Pageof 3

Frequent Collaborators

6 joint publications

Hideo Wada

2 joint publications

Yuki Kageyama

2 joint publications

Yasuhiko Hamada

2 joint publications

Kyosuke Tanaka